Thursday May 25th 2017

Archive for February, 2017

Perrigo to sell Tysabri drug royalty to RPI for $2.85bn

Perrigo to sell Tysabri drug royalty to RPI for $2.85bn

Ireland-based Perrigo has signed an agreement to sell its right to the royalty stream from the global net sales of the multiple sclerosis drug Tysabri (natalizumab) to Royalty Pharma ’s (RPI) affiliate RPI Finance Trust for $2.85bn. (Source: Pharmaceutical Technology) [Read More]

Society-Funded Mouse Study Shows Possible Mechanisms Underlying Flu Severity in People with MS

Society-Funded Mouse Study Shows Possible Mechanisms Underlying Flu Severity in People with MS

/About-the-Society/News/Society-Funded-Mouse-Study-Shows-Possible-Mechanis [Read More]

Anxiety, emotional processing and depression in people with multiple sclerosis – Gay MC, Bungener C, Thomas S, Vrignaud P, Thomas PW, Baker R, Montel…

Anxiety, emotional processing and depression in people with multiple sclerosis – Gay MC, Bungener C, Thomas S, Vrignaud P, Thomas PW, Baker R, Montel…

BACKGROUND: Despite the high comorbidity of anxiety and depression in people with multiple sclerosis (MS), little is known about their inter-relationships. Both involve emotional perturbations and the way in which emotions are processed is likely central t... (Source: [Read More]

 Page 1 of 29  1  2  3  4  5 » ...  Last » 

Latest Topics

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Hospitals vary widely in how often they transition people with strokes from active treatment to comfort or hospice care [Read More]

Roche investigating case of patient illness after taking MS drug

Roche investigating case of patient illness after taking MS drug

ZURICH (Reuters) - A person in Germany treated with Roche ’s new multiple sclerosis drug Ocrevus has been diagnosed [Read More]

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]